Kye Evans, DO
Undersea and Hyperbaric Medicine · Lawrence, KSNPI 1750397618
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,830 of the $2,440 with a category attached, or 75.0%. 14 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 25.0% of the total. Reporting peaked in 2019 at $713 and has fallen 52.3% since, to $340 in 2025.
Across 73 payments — averaging $33.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$610
- Organogenesis Inc.$559
- AbbVie$359
- Convatec Inc.$238
- Medtronic$155
- Tactile Systems Technology Inc$140
- plus $379 from 8 others
What the payments were for
- Travel & lodging$61025%
- Food & beverage$1,83075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 1 | $610 |
| Organogenesis Inc. | 28 | $559 |
| AbbVie | 9 | $359 |
| Convatec Inc. | 5 | $238 |
| Medtronic | 5 | $155 |
| Tactile Systems Technology Inc | 7 | $140 |
| Smith+Nephew | 4 | $91 |
| Kerecis Limited | 5 | $87 |
| Next Science LLC | 3 | $72 |
| Boston Scientific | 1 | $37 |
| Molnlycke Health Care US, LLC | 2 | $34 |
| Coloplast | 1 | $24 |
| Reprise Biomedical, Inc. | 1 | $19 |
| Osiris Therapeutics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$146
- DALVANCE$116
How this compares
Too few undersea and hyperbaric medicine providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 16 | $178 |
| Levofloxacin | 14 | $49 |
| Amoxicillin | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Lawrence
- Scott RobinsonLawrence$3K
- Richard HopkinsShawnee Mission$41K
- Justin GoodenWichita$11K
- Kenneth NewmanShawnee Mission$3K
- Michael NaglePittsburg$1K
- Laurie DelucaMerriam$1K
- Thomas WilliamsMerriam$472
- Douglas KellingKansas City$427
- John CarterTopeka$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.